Product ID: SQMIG35I2099
Report ID:
SQMIG35I2099 |
Region:
Global |
Published Date: February, 2024
Pages:
272
|
Tables:
156 |
Figures:
78
December 2020 The award-winning Canine Arthritis Management (CAM) team launched a new online course for dog professionals aimed at improving understanding of arthritis in dogs and its management.
August 2020 Zoetis joined forces with the WSAVA to support its global pain council (GPC), a group of global veterinarians who specialize in companion animal pain management. By providing educational and advisory resources, the GPC addressed global variations in animal pain assessment and management.
Elanco Animal Health's Zorbium (buprenorphine transdermal solution) was approved by the US Food and Drug Administration (FDA) in January 2022, expanding its pain management offerings while addressing an unmet need in veterinary practices.
The United States Food and Drug Administration approved Solensia (frunevetmab injection) in January 2022 as the first treatment for pain associated with osteoarthritis in cats.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONGlobal Veterinary Pain Management Market size was valued at USD 4.3 billion in 2019 and is poised to grow from USD 4.5 billion in 2023 to USD 6.12 billion by 2031, growing at a CAGR of 4.5% in the forecast period (2024-2031).
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Product ID: SQMIG35I2099